Literature DB >> 11597578

The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines.

J Bierau1, A H van Gennip, J Helleman, A B van Kuilenburg.   

Abstract

This paper describes the effects of cyclopentenyl cytosine (CPEC) on the proliferation and cell-cycle distribution of the SK-N-BE(2)c and SK-N-SH neuroblastoma cell lines, as well as their ability to recover from treatment with CPEC. The IC50 value of SK-N-BE(2)c for CPEC, determined after 48 hr was 80 nM. SK-N-BE(2)c cells showed a time- and concentration-dependent accumulation in the S-phase of the cell cycle after 2 and 3 days of incubation with 50-250 nM CPEC, followed by a G0/G1-phase arrest after 4 days. After incubation with 50 nM CPEC for 2 days, SK-N-BE(2)c cells fully recovered and resumed logarithmic proliferation. In contrast, a complete and persistent growth arrest occurred when SK-N-BE(2)c cells were incubated for 2 days with 100 or 250 nM CPEC. The IC50 value of SK-N-SH, determined after 48 hr, for CPEC was > or =1 microM. SK-N-SH cells incubated with 250 nM or 1 microM CPEC showed a time-dependent accumulation in the S-phase of the cell cycle, followed by an accumulation in the G0/G1-phase, which reached a maximum of 84.1% after 7 days of incubation with 1 microM CPEC. SK-N-SH cells did not resume proliferation after removal of the drug. In addition, CPEC strongly induced differentiation in SK-N-SH cells. After 48 hr incubation with 250 nM CPEC, 90% of the cell population was differentiated. Both neuronal type and Schwannian type cells were observed. We conclude that at very low concentrations, CPEC has profound cytostatic- and differentiation-inducing effects on the neuroblastoma cells studied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597578     DOI: 10.1016/s0006-2952(01)00756-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Prenatal growth restriction, retinal dystrophy, diabetes insipidus and white matter disease: expanding the spectrum of PRPS1-related disorders.

Authors:  Almundher Al-Maawali; Lucie Dupuis; Susan Blaser; Elise Heon; Mark Tarnopolsky; Fathiya Al-Murshedi; Christian R Marshall; Tara Paton; Stephen W Scherer; Jeroen Roelofsen; André B P van Kuilenburg; Roberto Mendoza-Londono
Journal:  Eur J Hum Genet       Date:  2014-06-25       Impact factor: 4.246

2.  The pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytes.

Authors:  N Nikolaeva; F J Bemelman; S-L Yong; A Verschuur; R A W van Lier; I J M ten Berge
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

Review 3.  Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas.

Authors:  Nikolaus von Knebel Doeberitz; Daniel Paech; Dominik Sturm; Stefan Pusch; Sevin Turcan; Yogen Saunthararajah
Journal:  Int J Cancer       Date:  2022-06-16       Impact factor: 7.316

4.  Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic status.

Authors:  Hamid Aslami; Wilco P Pulskens; Maria T Kuipers; Aafkeline P Bos; André B P van Kuilenburg; Ronald J A Wanders; Jeroen Roelofsen; Joris J T H Roelofs; Raphaela P Kerindongo; Charlotte J P Beurskens; Marcus J Schultz; Wim Kulik; Nina C Weber; Nicole P Juffermans
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

5.  Mysteries of partial dihydroorotate dehydrogenase inhibition and leukemia terminal differentiation.

Authors:  Yogen Saunthararajah
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.